These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38033415)

  • 1. Fertility-Sparing Surgery in Infiltrative Mucinous Carcinoma of the Ovary.
    Ben Ltaief S; Ghalleb M; Chabchoub A; Slimen M; Hadj Kacem L; Zenzeri Y; Chargui R; Dhieb T
    Case Rep Oncol; 2023; 16(1):1494-1499. PubMed ID: 38033415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.
    Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
    Oncologist; 2018 Mar; 23(3):324-327. PubMed ID: 29242280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?
    Gouy S; Saidani M; Maulard A; Faron M; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
    Gynecol Oncol Rep; 2017 Nov; 22():52-54. PubMed ID: 29022007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological and Reproductive Outcomes After Fertility-Sparing Surgery for Stage I Mucinous Ovarian Carcinoma.
    Lin W; Cao D; Shi X; You Y; Yang J; Shen K
    Front Oncol; 2022; 12():856818. PubMed ID: 35860580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of patients with early stage mucinous ovarian carcinoma: a Dutch population-based cohort study comparing expansile and infiltrative subtypes.
    Algera MD; Van de Vijver KK; van Driel WJ; Slangen BFM; Lof FC; van der Aa M; Kruitwagen RFPM; Lok CAR
    Int J Gynecol Cancer; 2024 May; 34(5):722-729. PubMed ID: 38460968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types.
    Gouy S; Saidani M; Maulard A; Faron M; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
    Gynecol Oncol Rep; 2017 Nov; 22():21-25. PubMed ID: 28971140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility-Sparing Surgery and Adjuvant Chemotherapy with Trastuzumab Result in Complete Remission in a Young Woman with Rare Primary Mucinous Ovarian Cancer due to ERBB2 Co-amplification with CDK12 and Chromosome 11q13.3 Amplicon: A Case Report and Literature Review.
    Gao L; Huang T; Zhong L; Peng L; Huang Z; Lu Y
    Reprod Sci; 2024 Jun; 31(6):1626-1631. PubMed ID: 38216775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of fertility sparing management in invasive mucinous ovarian carcinoma.
    Kim SR; Madariaga A; Hogen L; Vicus D; Covens A; Parra-Herran C; Lheureux S; Gien LT
    Gynecol Oncol; 2023 Jul; 174():129-132. PubMed ID: 37182433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation and Prognosis of Primary Expansile and Infiltrative Mucinous Carcinomas of the Ovary.
    Huin M; Lorenzini J; Arbion F; Carcopino X; Touboul C; Dabi Y; Kerbage Y; Costaz H; Lecointre L; Lavoué V; Bolze PA; Huchon C; Bricou A; Canlorbe G; Mimoun C; Bendifallah S; Gauthier T; Body G; Ouldamer L;
    J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294441
    [No Abstract]   [Full Text] [Related]  

  • 12. A patient with a mucinous borderline ovarian tumor after fertility-sparing surgery in whom puncture fluid cytology on oocyte retrieval led to a diagnosis of recurrence.
    Yoshiba T; Takei Y; Manaka Y; Suzuki T; Fujiwara H
    J Obstet Gynaecol Res; 2022 Oct; 48(10):2635-2639. PubMed ID: 35871537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epithelial ovarian cancer and fertility preservation: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Uzan C; Courbiere B; Chabbert-Buffet N
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):180-186. PubMed ID: 30704956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type.
    Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
    Int J Gynecol Cancer; 2018 Mar; 28(3):493-499. PubMed ID: 29466254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary invasive mucinous ovarian carcinoma of the intestinal type: importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases.
    Muyldermans K; Moerman P; Amant F; Leunen K; Neven P; Vergote I
    Eur J Cancer; 2013 May; 49(7):1600-8. PubMed ID: 23321546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
    Rodríguez IM; Prat J
    Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary mucinous ovarian cancer: options for surgery and chemotherapy.
    Kurnit KC; Frumovitz M
    Int J Gynecol Cancer; 2022 Oct; ():. PubMed ID: 36229081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
    Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility-sparing surgery for patients with stage IC2 or IC3 epithelial ovarian carcinoma: any evidence of safety?
    Nasioudis D; Heyward QD; Ko EM; Haggerty AF; Cory L; Giuntoli Ii RL; Kim SH; Latif NA
    Int J Gynecol Cancer; 2022 Feb; 32(2):165-171. PubMed ID: 34952848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.